The first part of our training series for frontline healthcare workers delves into the critical issue of stigma and bias within the treatment of birthing patients with substance use disorders. By addressing these deeply ingrained issues, we aim to empower healthcare workers to deliver compassionate and equitable care that ensures every individual seeking treatment receives the support they truly deserve.
The second part of our training series for frontline healthcare workers explores the principles of harm reduction and the potential to save lives by prioritizing safety and well-being over judgement. Through expert insights we learn how providing naloxone and other harm reduction strategies can foster trust between healthcare providers and birthing persons struggling with substance use, leading to more effective interventions and support.
The third part of our training series for frontline healthcare workers explores the world of evidence-based medication treatment for substance use disorders during the perinatal period. We navigate the complexities of utilizing medications to aid in recovery and explore the diverse options available, while highlighting important clinical pearls. By equipping healthcare workers with the latest insights, we empower them to play a pivotal role in supporting birthing persons on their path to recovery.
The fourth part of our training series for frontline healthcare workers focuses on the compassionate care of perinatal persons with substance use disorders. Our subject matter expert addresses the unique challenges and health implications these individuals face and brings a heightened understanding to some of the psychological and physiological barriers of these disorders. We offer valuable insights, evidence-based strategies and demonstrate how healthcare professionals can play a pivotal role in fostering healthy outcomes for the substance exposed dyad, through informed and empathetic care.
In reviewing the 2023 Illuminate SuPPoRT Colorado guidelines on Indications for Toxicology Testing in Colorado Birthing Facilities, the distinction between screening and toxicology testing is emphasized. Dr. Gold offers evidence-based recommendations for determining when toxicology testing is warranted and discusses the importance of establishing safe feeding plans as part of perinatal substance use prevention, recovery, and treatment efforts.
Toxicology testing has many limitations and complexities, often due to differences in methodologies and protocols between organizations. Challenges are common, such as delayed results, presence of false positives and false negatives and inconsistencies in accurate interpretation. Understanding of the differences between screening and toxicology testing is essential, as is the development of standardized approaches, considering the implications of toxicology testing on patients and families.
By emphasizing that unwarranted reports to child welfare can cause unnecessary stress and strain on families, we seek to rebuild trust in healthcare relationships and provide compassionate care for perinatal patients with SUDs. This video provides education that in Colorado not all substance use requires reporting; only when a child is directly affected and threatened by the substance use, is it necessary to make a report.
By shedding light on the intersection of substance use and pregnancy, we aspire to replace judgment with empathy, ensuring that every individual receives the care, understanding, and respect they deserve on their journey towards recovery and parenthood.
Through the recollection of personal stories, learn the importance of carrying naloxone and how you can become empowered to intervene in an overdose emergency, ultimately bridging the gap between life and tragedy.